{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:39:06Z","timestamp":1793338746845,"version":"4.5.0"},"reference-count":36,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2012,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Plague is one of the most dangerous diseases and is caused by\n            <jats:named-content content-type=\"genus-species\">Yersinia pestis<\/jats:named-content>\n            . Effective vaccine development requires understanding of immune protective mechanisms against the bacterium in humans. In this study, the humoral and memory cellular immune responses in plague patients (\n            <jats:italic>n<\/jats:italic>\n            = 65) recovered from\n            <jats:named-content content-type=\"genus-species\">Y. pestis<\/jats:named-content>\n            infection during the past 16 years were investigated using a protein microarray and an enzyme-linked immunosorbent spot assay (ELISpot). The seroprevalence to the F1 antigen in all recovered patients is 78.5%. In patients infected more than a decade ago, the antibody-positive rate still remains 69.5%. There is no difference in the antibody presence between gender, age, and infected years, but it seems to be associated with the F1 antibody titers during infection (\n            <jats:italic>r<\/jats:italic>\n            = 0.821;\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.05). Except F1 antibody, the antibodies against LcrV and YopD were detected in most of the patients, suggesting they could be the potential diagnostic markers for detecting the infection of F1-negative strains. Regarding cellular immunity, the cell number producing gamma interferon (IFN-\u03b3), stimulated by F1 and LcrV, respectively,\n            <jats:italic>in vitro<\/jats:italic>\n            to the peripheral blood mononuclear cells of 7 plague patients and 4 negative controls, showed no significant difference, indicating F1 and LcrV are not dominant T cell antigens against plague for a longer time in humans. Our findings have direct implications for the future design and development of effective vaccines against\n            <jats:named-content content-type=\"genus-species\">Y. pestis<\/jats:named-content>\n            infection and the development of new target-based diagnostics.\n          <\/jats:p>","DOI":"10.1128\/cvi.05559-11","type":"journal-article","created":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T05:07:55Z","timestamp":1324530475000},"page":"228-234","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":34,"title":["Humoral and Cellular Immune Responses to Yersinia pestis Infection in Long-Term Recovered Plague Patients"],"prefix":"10.1128","volume":"19","author":[{"given":"Bei","family":"Li","sequence":"first","affiliation":[{"name":"Institute of Biomedicine, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei Province, China"},{"name":"Laboratory of Analytical Microbiology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhong","family":"Du","sequence":"additional","affiliation":[{"name":"Yunnan Institute for Epidemic Diseases Control and Research, Dali, Yunnan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhou","sequence":"additional","affiliation":[{"name":"Laboratory of Analytical Microbiology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Bi","sequence":"additional","affiliation":[{"name":"Laboratory of Analytical Microbiology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Wang","sequence":"additional","affiliation":[{"name":"Laboratory of Analytical Microbiology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wen","sequence":"additional","affiliation":[{"name":"Institute of Biomedicine, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaobiao","family":"Guo","sequence":"additional","affiliation":[{"name":"Laboratory of Analytical Microbiology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhong","family":"Song","sequence":"additional","affiliation":[{"name":"Yunnan Institute for Epidemic Diseases Control and Research, Dali, Yunnan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifu","family":"Yang","sequence":"additional","affiliation":[{"name":"Laboratory of Analytical Microbiology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.11.4580-4585.1996"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1128\/IAI.67.3.1533-1537.1999","article-title":"Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestis","volume":"67","author":"Andrews GP","year":"1999","unstructured":"AndrewsGP. 1999. Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestis. Infect. Immun. 67:1533\u20131537.","journal-title":"Infect. Immun."},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1128\/IAI.67.4.1922-1928.1999","article-title":"Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice","volume":"67","author":"Benner GE","year":"1999","unstructured":"BennerGE. 1999. Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice. Infect. Immun. 67:1922\u20131928.","journal-title":"Infect. Immun."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0803.010250"},{"key":"e_1_3_2_6_2","first-page":"804","article-title":"The plague, possible bioterrorist act","volume":"32","author":"Bossi P","year":"2003","unstructured":"BossiP BricaireF. 2003. The plague, possible bioterrorist act. Presse Med. 32:804\u2013807. (In French.)","journal-title":"Presse Med."},{"key":"e_1_3_2_7_2","first-page":"39","article-title":"The serological response to Yersinia pestis infection","volume":"55","author":"Butler T","year":"1977","unstructured":"ButlerT HudsonBW. 1977. The serological response to Yersinia pestis infection. Bull. World Health Organ. 55:39\u201342.","journal-title":"Bull. World Health Organ."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1286-4579(00)00289-6"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJM199709043371010","article-title":"Multidrug resistance in plague","volume":"337","author":"Dennis DT","year":"1997","unstructured":"DennisDT HughesJM. 1997. Multidrug resistance in plague. N. Engl. J. Med. 337:702\u2013704.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0264-410X(98)80110-2","article-title":"Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine","volume":"16","author":"Heath DG","year":"1998","unstructured":"HeathDG. 1998. Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine 16:1131\u20131137.","journal-title":"Vaccine"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.mimet.2010.08.005","article-title":"Development of an up-converting phosphor technology-based 10-channel lateral flow assay for profiling antibodies against Yersinia pestis","volume":"83","author":"Hong W","unstructured":"HongW. Development of an up-converting phosphor technology-based 10-channel lateral flow assay for profiling antibodies against Yersinia pestis. J. Microbiol. Methods 83:133\u2013140.","journal-title":"J. Microbiol. Methods"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"6866","DOI":"10.1016\/j.vaccine.2011.07.059","article-title":"T cells play an essential role in anti-F1 mediated rapid protection against bubonic plague","volume":"29","author":"Levy Y","year":"2011","unstructured":"LevyY. 2011. T cells play an essential role in anti-F1 mediated rapid protection against bubonic plague. Vaccine 29:6866\u20136873.","journal-title":"Vaccine"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"799","DOI":"10.4269\/ajtmh.2008.79.799","article-title":"Serologic survey of the sentinel animals for plague surveillance and screening for complementary diagnostic markers to F1 antigen by protein microarray","volume":"79","author":"Li B","year":"2008","unstructured":"LiB. 2008. Serologic survey of the sentinel animals for plague surveillance and screening for complementary diagnostic markers to F1 antigen by protein microarray. Am. J. Trop. Med. Hyg. 79:799\u2013802.","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.6.3734-3739.2005"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01517-07"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.micinf.2007.10.003","article-title":"Antibody profiling in plague patients by protein microarray","volume":"10","author":"Li B","year":"2008","unstructured":"LiB. 2008. Antibody profiling in plague patients by protein microarray. Microbes Infect. 10:45\u201351.","journal-title":"Microbes Infect."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00242-09"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.diagmicrobio.2008.10.020","article-title":"Development of up-converting phosphor technology-based lateral-flow assay for rapidly quantitative detection of hepatitis B surface antibody","volume":"63","author":"Li L","year":"2009","unstructured":"LiL. 2009. Development of up-converting phosphor technology-based lateral-flow assay for rapidly quantitative detection of hepatitis B surface antibody. Diagn. Microbiol. Infect. Dis. 63:165\u2013172.","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"e_1_3_2_19_2","first-page":"342","article-title":"The production and immunity of FraI of Yersinia pestis","volume":"8","author":"Li T","year":"1993","unstructured":"LiT LiuX DaiY. 1993. The production and immunity of FraI of Yersinia pestis. Chin. J. Control Endemic Dis. 8:342\u2013344.","journal-title":"Chin. J. Control Endemic Dis."},{"key":"e_1_3_2_20_2","first-page":"653","article-title":"Effectiveness of live or killed plague vaccines in man","volume":"42","author":"Meyer KF","year":"1970","unstructured":"MeyerKF. 1970. Effectiveness of live or killed plague vaccines in man. Bull. World Health Organ. 42:653\u2013656.","journal-title":"Bull. World Health Organ."},{"key":"e_1_3_2_21_2","first-page":"1","article-title":"Prevention of plague: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"45","author":"MMWR Recomm. Rep","year":"1996","unstructured":"MMWR Recomm. Rep. 1996. Prevention of plague: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 45:1\u201315.","journal-title":"MMWR Recomm. Rep."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.11.7304-7310.2005"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.3.1532-1542.2005"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01529-06"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.vaccine.2009.02.078","article-title":"Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270","volume":"28","author":"Qi Z","year":"2010","unstructured":"QiZ. 2010. Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270. Vaccine 28:1655\u20131660.","journal-title":"Vaccine"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.mimet.2009.07.015","article-title":"Rapid and quantitative detection of Brucella by up-converting phosphor technology-based lateral-flow assay","volume":"79","author":"Qu Q","year":"2009","unstructured":"QuQ. 2009. Rapid and quantitative detection of Brucella by up-converting phosphor technology-based lateral-flow assay. J. Microbiol. Methods 79:121\u2013123.","journal-title":"J. Microbiol. Methods"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00105-08"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/cdli.4.5.587-591.1997"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0264-410X(97)00305-8","article-title":"Comparison of the immunological and protective responses elicited by microencapsulated formulations of the F1 antigen from Yersinia pestis","volume":"16","author":"Reddin KM","year":"1998","unstructured":"ReddinKM. 1998. Comparison of the immunological and protective responses elicited by microencapsulated formulations of the F1 antigen from Yersinia pestis. Vaccine 16:761\u2013767.","journal-title":"Vaccine"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/0264-410X(95)00090-N","article-title":"A comparison of plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model","volume":"13","author":"Russell P","year":"1995","unstructured":"RussellP. 1995. A comparison of plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine 13:1551\u20131556.","journal-title":"Vaccine"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1517\/14712598.4.6.965","article-title":"Yersinia pestis (plague) vaccines","volume":"4","author":"Titball RW","year":"2004","unstructured":"TitballRW WilliamsonED. 2004. Yersinia pestis (plague) vaccines. Expert Opin. Biol. Ther. 4:965\u2013973.","journal-title":"Expert Opin. Biol. Ther."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00386-10"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00305-09"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00119-6"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.6.3598-3608.2005"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2249.1999.00859.x","article-title":"An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model","volume":"116","author":"Williamson ED","year":"1999","unstructured":"WilliamsonED. 1999. An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model. Clin. Exp. Immunol. 116:107\u2013114.","journal-title":"Clin. Exp. Immunol."},{"key":"e_1_3_2_37_2","first-page":"325","article-title":"Construction of defined F1 negative mutants of virulent Yersinia pestis","volume":"13","author":"Worsham PL","year":"1995","unstructured":"WorshamPL SteinMP WelkosSL. 1995. Construction of defined F1 negative mutants of virulent Yersinia pestis. Contrib. Microbiol. Immunol. 13:325\u2013328.","journal-title":"Contrib. Microbiol. Immunol."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.05559-11","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.05559-11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:46:56Z","timestamp":1627591616000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.05559-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["10.1128\/CVI.05559-11"],"URL":"https:\/\/doi.org\/10.1128\/cvi.05559-11","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"2011-11-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-12-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-01-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}